ARVINAS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ARVINAS, INC. (ARVN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $4.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $4.00M, a 900.00% increase year-over-year.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $600.00K, a 77.78% decline year-over-year.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$3.00M, a 600.00% decline year-over-year.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$5.40M, a 1450.00% decline year-over-year.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$5.30M, a 175.71% decline from fiscal 2024.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $7.00M.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$14.10M, a 883.33% decline from fiscal 2022.
- ARVINAS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.80M, a 86.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.60M 10-Q · filed 2026-08-04 | $1.60M derived: sum of 3 quarters · filed 2026-08-04 | -$3.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $600.00K 10-Q · filed 2026-05-11 | -$2.40M derived: sum of 2 quarters · filed 2026-05-11 | -$7.80M derived: sum of 3 quarters · filed 2026-05-11 | -$7.40M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$8.40M derived: sum of 2 quarters · filed 2026-02-24 | -$8.00M derived: sum of 3 quarters · filed 2026-08-04 | -$5.30M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.00M derived: sum of 2 quarters · filed 2026-08-04 | -$2.30M 10-Q · filed 2025-11-05 | -$1.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.10M 10-Q · filed 2026-08-04 | $3.70M derived: sum of 3 quarters · filed 2026-08-04 | $4.10M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $2.70M 10-Q · filed 2026-05-11 | $3.30M derived: sum of 2 quarters · filed 2026-05-11 | $3.70M derived: sum of 3 quarters · filed 2026-05-11 | $7.80M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.00M derived: sum of 2 quarters · filed 2026-02-24 | $5.10M derived: sum of 3 quarters · filed 2026-02-24 | $7.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.50M derived: sum of 2 quarters · filed 2025-11-05 | $6.40M 10-Q · filed 2025-11-05 | $4.60M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $6.00M 10-Q · filed 2025-08-06 | $4.20M derived: sum of 3 quarters · filed 2026-02-24 | $5.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $1.90M 10-Q · filed 2025-05-01 | $100.00K derived: sum of 2 quarters · filed 2026-02-24 | $900.00K derived: sum of 3 quarters · filed 2026-02-24 | -$5.30M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.00M derived: sum of 2 quarters · filed 2026-02-24 | -$7.20M derived: sum of 3 quarters · filed 2026-02-24 | -$14.10M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$5.40M derived: sum of 2 quarters · filed 2024-10-30 | -$12.30M 10-Q · filed 2024-10-30 | -$12.50M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-06-30 | -$6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$13.10M 10-Q · filed 2024-07-30 | -$13.30M derived: sum of 3 quarters · filed 2025-02-11 | -$12.30M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-03-31 | -$6.90M 10-Q · filed 2024-05-07 | -$7.10M derived: sum of 2 quarters · filed 2025-02-11 | -$6.10M derived: sum of 3 quarters · filed 2025-02-11 | -$2.80M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2022-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $800.00K derived: sum of 2 quarters · filed 2025-02-11 | $4.10M derived: sum of 3 quarters · filed 2025-02-11 | $1.80M 10-K · filed 2025-02-11 | ||||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.30M derived: sum of 2 quarters · filed 2023-11-07 | $2.00M 10-Q · filed 2023-11-07 | $3.20M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.00M 10-Q · filed 2023-08-08 | $2.20M derived: sum of 3 quarters · filed 2024-02-27 | $5.50M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | -$2.30M 10-Q · filed 2023-05-05 | -$1.10M derived: sum of 2 quarters · filed 2024-02-27 | $2.20M derived: sum of 3 quarters · filed 2024-02-27 | $9.20M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.50M derived: sum of 2 quarters · filed 2024-02-27 | $11.50M derived: sum of 3 quarters · filed 2024-02-27 | $13.60M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $10.30M derived: sum of 2 quarters · filed 2022-11-09 | $12.40M 10-Q · filed 2022-11-09 | $12.42M 10-Q · filed 2021-11-03 | $15.07M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $9.10M 10-Q · filed 2022-08-04 | $9.13M 10-Q · filed 2021-08-05 | $11.77M derived: sum of 3 quarters · filed 2023-02-23 | $11.90M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | $2.10M 10-Q · filed 2022-05-05 | $2.10M 10-Q · filed 2021-05-04 | $4.77M derived: sum of 2 quarters · filed 2023-02-23 | $4.90M derived: sum of 3 quarters · filed 2023-02-23 | $4.74M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.80M derived: sum of 2 quarters · filed 2023-02-23 | $2.64M derived: sum of 3 quarters · filed 2023-02-23 | $2.40M 10-K · filed 2023-02-23 | $2.39M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $139.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$22.38K derived: sum of 2 quarters · filed 2021-11-03 | -$265.41K 10-Q · filed 2021-11-03 | -$448.28K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | -$161.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$404.67K 10-Q · filed 2021-08-05 | -$587.53K derived: sum of 3 quarters · filed 2022-02-28 | $677.80K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$243.04K 10-Q · filed 2021-05-04 | -$425.90K derived: sum of 2 quarters · filed 2022-02-28 | $839.43K derived: sum of 3 quarters · filed 2022-02-28 | $1.22M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$182.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.08M derived: sum of 2 quarters · filed 2022-02-28 | $1.46M derived: sum of 3 quarters · filed 2022-02-28 | $1.10M 10-K · filed 2022-02-28 | $1.07M 10-K · filed 2020-03-16 | |||
| 2019-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.65M derived: sum of 2 quarters · filed 2020-11-05 | $1.28M 10-Q · filed 2020-11-05 | $1.22M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $380.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $17.53K 10-Q · filed 2020-08-04 | -$46.24K derived: sum of 3 quarters · filed 2021-03-01 | $844.87K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$363.43K 10-Q · filed 2020-04-28 | -$427.20K derived: sum of 2 quarters · filed 2021-03-01 | $463.90K derived: sum of 3 quarters · filed 2021-03-01 | $2.14M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$63.77K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $827.34K derived: sum of 2 quarters · filed 2021-03-01 | $2.51M derived: sum of 3 quarters · filed 2021-03-01 | $2.50M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $891.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $2.57M derived: sum of 2 quarters · filed 2019-11-04 | $2.57M 10-Q · filed 2019-11-04 | $2.59M derived: sum of 4 quarters · filed 2019-11-04 | ||||
| 2018-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $1.67M 10-Q · filed 2019-08-05 | $1.70M derived: sum of 3 quarters · filed 2019-08-05 | |||||
| 2018-03-31 | -$5.06K 10-Q · filed 2019-05-09 | $19.94K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $2.06K 10-K · filed 2019-03-26 | ||||||
| 2017-09-30 | -$22.94K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |